Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

   19,500      
Direct Value   $6,622,171    

Indirect Value

   $117,000      
Total Shares   312,921      
Total Value   $6,739,171      


Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $881,514 Biocryst Pharmaceuticals Inc $289,459 Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $881,514 Biocryst Pharmaceuticals Inc $289,459
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    5    

     Stock price went up :
    0   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   1.5   
     Percentage Gain/Loss :
   -31.1%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 63,339 2019-03-12 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACER Acer Therapeutics Inc   •       •      –    2017-09-19 4 A $0.00 $0 D/D 11,905 11,905 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2014-11-06 4 A $0.00 $0 D/D 100,000 361,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2014-11-20 4 B $8.20 $10,660 D/D 1,300 363,056 2.81 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2014-11-21 4 B $8.50 $73,950 D/D 8,700 371,756 2.81 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2015-09-11 4 GD $0.00 $0 D/D 3,000 368,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2015-11-09 4 AS $18.77 $563,100 D/D (30,000) 338,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2015-11-10 4 AS $18.72 $561,600 D/D (30,000) 308,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-01-27 4 GD $0.00 $0 D/D 3,000 305,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-21 4 GD $0.00 $0 D/D 57,000 248,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-21 4 S $21.00 $105,000 D/D (5,000) 243,756 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2016-11-22 4 S $21.30 $68,160 D/D (3,200) 240,556 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2017-06-14 4 S $17.85 $89,250 D/D (5,000) 245,556 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2017-12-21 4 GD $0.00 $0 D/D 5,000 240,556 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2017-12-26 4 GD $0.00 $0 D/D 23,000 217,556 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-02-08 4 A $0.00 $0 D/D 3,549 221,105 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-03-07 4 OE $6.00 $1,668 D/D 278 221,383 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-05-10 4 A $0.00 $0 D/D 24,500 245,883 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-08-31 4 AS $32.00 $384,000 D/D (12,000) 245,883 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-08-31 4 OE $8.70 $104,400 D/D 12,000 257,883 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-09 4 A $0.00 $0 D/D 18,500 264,383 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-14 4 AS $23.63 $131,735 D/D (5,550) 258,833 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-15 4 AS $24.21 $134,969 D/D (5,550) 253,283 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-11-29 4 GD $0.00 $0 D/D 1,750 251,533 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-12-07 4 S $24.04 $240 D/D (10) 251,523 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-12-18 4 A $0.00 $0 D/D 20,625 272,148 0 -
  169  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us